Kiromic BioPharma

Kiromic BioPharma, Inc. is an AI-driven end-to-end CAR-T and gene therapy company that has developed the first multi-indication allogeneic CAR-T cell therapy, harnessing the natural potency of γ δ T cells to target solid tumors.